|
| Home : Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe |
|
Dec 28
2020 |
Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe |
|
SALT LAKE CITY, Dec. 28, 2020 /PRNewswire/ -- Elevar Therapeutics, Inc. ("Elevar"), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced that it... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/elevar-therapeutics-announces-licensing-agreement-with-inceptua-group-for-commercialization-of-apealea-paclitaxel-micellar-in-europe-301198507.html |
| |
|
Related News
|
» Voyager Digital Reaches $200 Million in Assets Under Management
» Authorities: Utah's Ty Jordan died in accidental shooting
|
|
|
